Black Box Warnings .
admin. only under supervision of physician experienced in cancer chemotherapy
severe myelosuppression leading to infection or bleeding may occur; incr. myelosuppression w/ IV formulation compared to oral formulation
occur in 2% of pts receiving IV formulation, incl. anaphylaxis
incl. acute nonlymphocytic leukemia
produces chromosomal aberrations in vitro and in vivo, thus consider potentially mutagenic in humans
Adult Dosing .
Dosage forms: IV
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments
multiple myeloma, palliative tx
- [IV route]
- Dose: 16 mg/m^2 IV x1 on day 1 of 28-day cycle, starting cycle 5; Start: 16 mg/m^2 IV x1 on day 1 of 14-day cycle x4 cycles
- [adjust dose amount]
- mod-severe impairment: decr. start dose, amount not defined; HD/PD: not defined
- [not defined]
- hepatic impairment: caution advised
Peds Dosing .
Peds dosing is currently unavailable or not applicable for this drug.
- hypersens. to drug/class/compon.
- prior melphalan resistance
- pregnancy 1st trimester
- caution if CLL
- caution if renal impairment, mod-severe
- caution if hepatic impairment
Drug Interactions .
alkylating agent, nitrogen mustard
- immuno-myelosuppressive chemo
- adenovirus vaccine, live
- BCG live intravesical
- influenza nasal vaccine, live
- measles/mumps/rubella vaccine, live
- rotavirus vaccine, live
- smallpox vaccine (live vaccinia virus)
- typhoid vaccine, live
- varicella vaccine, live
- yellow fever vaccine, live
- zoster vaccine, live
- radium Ra 223 dichloride
- interferon alfacon-1
- interferon beta 1a
- mycophenolate mofetil
- mycophenolic acid
- anthrax vaccine
- diphtheria/tetanus and/or pertussis vaccine
- Haemophilus b conjugate vaccine
- hepatitis A vaccine
- hepatitis B vaccine
- human papillomavirus vaccine
- influenza H5N1 vaccine (avian flu)
- influenza vaccine
- Japanese encephalitis vaccine
- meningococcal vaccine
- pneumococcal vaccine
- poliovirus vaccine
- rabies vaccine
- typhoid vi polysaccharide vaccine
Adverse Reactions .
- hypersensitivity rxn
- secondary malignancy (long-term use)
- acute nonlymphocytic leukemia (long-term use)
- myeloproliferative syndrome (long-term use)
- bone marrow failure
- anemia, hemolytic
- cardiac arrest
- hepatic veno-occlusive dz
- interstitial pneumonitis
- pulmonary fibrosis
- extravasation/tissue damage (IV use)
- infertility (long-term use)
- injection site rxn (IV use)
- maculopapular rash
- ALT, AST elevated
- pulmonary infiltrates
Cr at baseline; CBC w/ diff at baseline, prior to each dose, and periodically
Look/Sound-Alike Drug Names
melphalan confused with: Mellaril; Myleran
Metabolism: plasma; CYP450: unknown
Excretion: feces 20-50%, urine (10% unchanged); Half-life: 60-90min
Subclass: Alkylating Agents 1: Nitrogen Mustards
Mechanism of Action
alkylates and cross-links DNA, inhibiting nucleic acid and protein synthesis
Approximate Retail Price
This information is currently not available for this drug.
Join Now to View Patient Handouts!
Create a FREE Epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.
Current Members: Sign In.